Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Inspire Medical Systems, Inc. (INSP)

NYSE Health Care Health Care Equipment S&P SmallCap 600
$63.98
-2.55 (-3.83%)
Close of Nov 06, 2026 · end-of-day data
Source: Inspire Medical Systems, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 03, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$16.43M$28.57M$50.59M$82.05M$115.38M$233.39M$407.86M$624.80M$802.80M$911.98M
Cost of revenue$3.90M$6.02M$10.06M$13.64M$17.62M$33.28M$66.11M$96.58M$122.99M$133.22M
Gross profit$12.52M$22.55M$40.54M$68.41M$97.76M$200.12M$341.74M$528.22M$679.82M$778.76M
Research & development$7.09M$6.19M$7.39M$12.84M$26.09M$37.35M$68.64M$116.54M$114.13M$103.17M
Selling, general & admin$22.68M$32.36M$53.53M$90.47M$127.87M$202.62M$320.69M$451.96M$529.61M$624.64M
Operating income-$17.25M-$16.00M-$20.38M-$34.90M-$56.21M-$39.85M-$47.59M-$40.27M$36.08M$50.95M
Interest expense$1.30M$1.75M$3.30M$2.12M$2.12M$2.13M$1.68M$0$22.00K$137.00K
Pre-tax income-$18.53M-$17.51M-$21.83M-$33.20M-$57.09M-$41.97M-$44.27M-$19.91M$58.45M$65.70M
Income tax$0$0$0$40.00K$115.00K$72.00K$613.00K$1.25M$4.94M-$79.72M
Net income-$18.53M-$17.51M-$21.83M-$33.24M-$57.20M-$42.04M-$44.88M-$21.15M$53.51M$145.42M
EBITDA-$17.15M-$15.72M-$19.98M-$34.40M-$55.37M-$38.63M-$45.73M-$37.42M$42.63M$64.91M
EPS (basic)$-16.90$-14.88$-1.50$-1.40$-2.19$-1.54$-1.60$-0.72$1.80$4.95
EPS (diluted)$-16.90$-14.88$-1.50$-1.40$-2.19$-1.54$-1.60$-0.72$1.75$4.89
Diluted shares1.10M1.18M14.58M23.80M26.07M27.26M28.07M29.30M30.54M29.76M
Gross margin76.2%78.9%80.1%83.4%84.7%85.7%83.8%84.5%84.7%85.4%
Operating margin-105.0%-56.0%-40.3%-42.5%-48.7%-17.1%-11.7%-6.4%4.5%5.6%
Net margin-112.8%-61.3%-43.1%-40.5%-49.6%-18.0%-11.0%-3.4%6.7%15.9%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$6.68M$8.96M$97.29M$22.86M$190.52M$214.47M$441.59M$185.54M$150.15M$104.81M
Short-term investments—$7.19M$90.92M$126.61M$43.84M$0$9.82M$274.84M$295.40M$203.46M
Receivables—$3.86M$6.67M$13.13M$25.06M$34.18M$61.23M$89.88M$93.07M$119.69M
Inventory—$3.67M$2.67M$5.83M$8.48M$17.23M$11.89M$33.88M$80.12M$145.29M
Total current assets—$24.10M$199.28M$170.64M$269.87M$268.54M$530.03M$593.74M$630.81M$583.65M
Total assets—$25.09M$200.08M$181.25M$281.19M$295.08M$564.88M$676.81M$808.38M$907.32M
Total current liabilities—$7.15M$11.15M$16.86M$20.73M$41.31M$61.19M$78.11M$88.50M$96.06M
Long-term debt——$24.50M$24.50M$24.50M$24.50M————
Total debt——$24.50M$24.50M$24.50M$24.50M————
Total liabilities—$23.76M$36.08M$41.42M$51.44M$66.04M$68.87M$104.30M$118.69M$126.16M
Shareholders' equity-$6.61M$1.33M$164.00M$139.84M$229.75M$229.05M$496.01M$572.51M$689.70M$781.16M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$17.95M-$15.79M-$18.69M-$32.85M-$53.05M-$20.12M$11.57M$24.65M$130.25M$116.98M
Capital expenditures$306.00K$412.00K$250.00K$2.74M$2.46M$4.67M$9.10M$23.63M$39.12M$38.50M
Free cash flow-$18.25M-$16.20M-$18.94M-$35.59M-$55.50M-$24.79M$2.47M$1.02M$91.12M$78.48M
Investing cash flow-$306.00K-$7.60M-$83.39M-$43.56M$86.63M$29.14M-$19.60M-$294.82M-$113.12M$21.45M
Financing cash flow$12.81M$25.66M$190.38M$1.96M$134.06M$14.95M$235.08M$13.95M-$52.39M-$183.45M
Share buybacks——————$0$0$0$175.02M
Stock-based compensation$248.00K$243.00K$1.22M$6.20M$12.82M$26.18M$51.97M$82.47M$116.01M$130.26M
Depreciation & amortization$103.00K$285.00K$393.00K$495.00K$840.00K$1.22M$1.86M$2.85M$6.55M$13.96M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.